DiscoverPsychiatric Services From Pages to Practice71: Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction
71: Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction

71: Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction

Update: 2024-11-18
Share

Description

Dr. Mette Ødegaard Nielsen (Unit for Complicated Schizophrenia, Glostrup, Denmark) joins Dr. Dixon and Dr. Berezin to discuss patient motivations and experiences of antipsychotic medication tapering at a clinic in Denmark.

Transcript

  • 01:02      Nielsen interview
  • 02:22      Tapering medication
  • 04:09      Controversies around tapering
  • 07:07      Debilitating effects of side effects
  • 09:09      The tension between medication and side effects for the clinician
  • 12:47      Top line findings
  • 15:28      Psychotic symptom relapse
  • 17:38      Differences by medication
  • 19:43      Expectations from patients
  • 21:47      Shared decision making
  • 24:44      Mixed expectations and reality
  • 27:20      Relapse
  • 29:50      Close contact between patients and clinic staff

Subscribe to the podcast here.

Check out Editor's Choice, a set of curated collections from the rich resource of articles published in the journal. Sign up to receive notification of new Editor's Choice collections.

Browse other articles on our website.

Be sure to let your colleagues know about the podcast, and please rate and review it wherever you listen to it.

Listen to other podcasts produced by the American Psychiatric Association.

Follow the journal on Twitter.

E-mail us at 
psjournal@psych.org

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

71: Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction

71: Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction